Guardant Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on May 8, 2023, covering events occurring on May 3, 2023. The filing primarily addresses the appointment of a new senior executive officer.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
On May 3, 2023, the Board of Directors appointed Ines Dahne-Steuber as Chief Operations Officer, effective immediately. This represents a material change in the Company's executive leadership team.
Management Commentary and Compensation Details
Ms. Dahne-Steuber, previously a senior executive at Fresenius Medical Care and Quest Diagnostics, entered into an employment agreement with the following terms:
- Base Salary: $490,000 annually.
- Target Bonus: 50% of annual base salary.
- Equity Grants:
- Restricted Stock Units (RSUs) valued at approximately $2,000,000, vesting ratably over four years.
- Stock options to purchase shares valued at approximately $2,000,000, with 25% vesting on the first anniversary and the remainder monthly thereafter over four years.
- Signing Bonus: $50,000.
- Relocation Allowance: Up to $50,000.
Both the signing bonus and relocation allowance are subject to clawback on a prorated basis if Ms. Dahne-Steuber voluntarily terminates employment within 12 months. She has also agreed to standard restrictive covenants and an indemnification agreement.
Investor Verification Checklist
- Verify the total value of equity grants ($4,000,000 combined value) against current stock price to determine share counts.
- Review the vesting schedules to understand future dilution and retention incentives.
- Confirm the impact of the new COO's operational background on the company's strategic direction.
- Note that no financial performance data is included in this specific filing; refer to recent 10-Q or 10-K filings for financial metrics.